Total Payments
$3,966
2024 Payments
$711.71
Companies
33
Transactions
195
Medicare Patients
1,334
Medicare Billing
$50,704
Payment Breakdown by Category
Food & Beverage$3,966 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,966 | 195 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $570.16 | 35 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $516.07 | 16 | $0 (2023) |
| Novo Nordisk Inc | $448.60 | 27 | $0 (2024) |
| Lilly USA, LLC | $386.62 | 19 | $0 (2023) |
| GENZYME CORPORATION | $166.34 | 4 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $158.42 | 8 | $0 (2022) |
| Inspire Medical Systems, Inc. | $155.94 | 4 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $150.92 | 9 | $0 (2023) |
| GlaxoSmithKline, LLC. | $141.98 | 9 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $133.73 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $711.71 | 19 | Inspire Medical Systems, Inc. ($155.94) |
| 2023 | $1,259 | 75 | ABBVIE INC. ($325.60) |
| 2022 | $1,668 | 82 | Bayer HealthCare Pharmaceuticals Inc. ($381.33) |
| 2021 | $326.74 | 19 | BOSTON SCIENTIFIC CORPORATION ($51.58) |
All Payment Transactions
195 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: NEUROLOGY | ||||||
| 11/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $104.43 | General |
| Category: Obesity | ||||||
| 11/07/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/05/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $11.18 | General |
| Category: NEUROLOGY | ||||||
| 09/16/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: Endocrinology | ||||||
| 07/29/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: Endocrinology | ||||||
| 07/19/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: NEUROLOGY | ||||||
| 06/26/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Endocrinology | ||||||
| 06/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $112.20 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: NEUROSCIENCE | ||||||
| 04/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $110.67 | General |
| Category: Immunology | ||||||
| 03/21/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Endocrinology | ||||||
| 02/23/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: NEUROSCIENCE | ||||||
| 02/12/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Endocrinology | ||||||
| 01/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Immunology | ||||||
| 01/24/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: NEUROSCIENCE | ||||||
| 01/18/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $109.69 | General |
| Category: NEUROLOGY | ||||||
| 12/05/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: Immunology | ||||||
| 11/10/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.55 | General |
| Category: NEUROSCIENCE | ||||||
| 11/10/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $1.21 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $31.17 | General |
| Category: NEUROSCIENCE | ||||||
| 09/29/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 359 | 423 | $49,155 | $10,290 |
| 2022 | 20 | 733 | 949 | $120,430 | $30,207 |
| 2021 | 11 | 242 | 277 | $35,820 | $10,207 |
Total Patients
1,334
Total Services
1,649
Medicare Billing
$50,704
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 36 | 43 | $7,955 | $2,635 | 33.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 47 | 52 | $8,060 | $1,931 | 24.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 16 | 16 | $3,600 | $1,638 | 45.5% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 14 | 14 | $1,820 | $810.58 | 44.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 41 | 50 | $5,750 | $517.50 | 9.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 43 | 61 | $3,355 | $512.40 | 15.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 27 | 29 | $4,205 | $477.34 | 11.4% |
| 82306 | Vitamin d-3 level | Office | 2023 | 13 | 15 | $1,425 | $435.15 | 30.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 44 | 54 | $4,590 | $410.94 | 9.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 27 | 30 | $4,050 | $393.60 | 9.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 22 | 27 | $2,025 | $257.04 | 12.7% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 16 | 16 | $1,760 | $236.48 | 13.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 13 | 16 | $560.00 | $35.20 | 6.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 94 | 152 | $28,120 | $10,435 | 37.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 90 | 133 | $20,615 | $5,770 | 28.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 40 | 40 | $9,000 | $4,069 | 45.2% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 11 | 11 | $3,080 | $1,452 | 47.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 11 | $4,350 | $982.77 | 22.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 13 | 13 | $1,775 | $819.20 | 46.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 64 | 76 | $8,740 | $791.75 | 9.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 70 | 93 | $7,905 | $713.01 | 9.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 50 | 53 | $7,155 | $701.80 | 9.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 38 | 41 | $5,945 | $680.47 | 11.4% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 20 | 21 | $2,730 | $640.44 | 23.5% |
| 82306 | Vitamin d-3 level | Office | 2022 | 21 | 21 | $1,995 | $613.91 | 30.8% |
About Sarah New, NP
Sarah New, NP is a Primary Care healthcare provider based in Grovetown, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/19/2021. The National Provider Identifier (NPI) number assigned to this provider is 1598355174.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sarah New, NP has received a total of $3,966 in payments from pharmaceutical and medical device companies, with $711.71 received in 2024. These payments were reported across 195 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($3,966).
As a Medicare-enrolled provider, New has provided services to 1,334 Medicare beneficiaries, totaling 1,649 services with total Medicare billing of $50,704. Data is available for 3 years (2021–2023), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Primary Care
- Location Grovetown, GA
- Active Since 01/19/2021
- Last Updated 09/06/2024
- Taxonomy Code 363LP2300X
- Entity Type Individual
- NPI Number 1598355174
Products in Payments
- Kerendia (Drug) $516.07
- MOUNJARO (Drug) $315.37
- VRAYLAR (Drug) $279.59
- DUPIXENT (Biological) $205.53
- Rybelsus (Drug) $176.51
- INSPIRE (Device) $155.94
- QUVIVIQ (Drug) $150.92
- UBRELVY (Drug) $150.42
- TOUJEO (Biological) $146.55
- TRELEGY ELLIPTA (Drug) $141.98
- QULIPTA (Drug) $140.15
- Wegovy (Drug) $127.49
- JARDIANCE (Drug) $118.37
- VOQUEZNA (Drug) $112.20
- NURTEC ODT (Drug) $105.51
- XIFAXAN (Drug) $102.39
- Dexcom G6 Transmitter (Medical Supply) $101.23
- Ozempic (Drug) $93.24
- ENTRESTO (Drug) $77.75
- SPRAVATO (Drug) $75.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.